#Bioretec #Finland #Tampere #Annual General Meeting

Notice of Annual General Meeting of Bioretec Ltd

Bioretec Ltd has announced that it will hold its Annual General Meeting (AGM) on March 21, 2025, at 11:00 a.m. Finnish time. The meeting will take place at their office located at Yrittäjänkulma 5, in Tampere, Finland. Shareholders are encouraged to attend and exercise their rights through proxy representation if necessary.

Registration Details

For those wishing to participate in the AGM, registration is mandatory and must be completed by March 11, 2025, at 4:00 p.m. Finnish time. Shareholders can register via email, phone, or by mail, and must provide the required identification and contact information.

Meeting Agenda

The agenda for the AGM includes several important items:
1. Opening of the meeting.
2. Election of inspectors for the minutes and vote counting.
3. Verification of the meeting's legality.
4. Presentation and approval of the financial statements for the previous year, alongside the Board of Directors' report and auditor's report.
5. Discussion on the company's loss from the last financial year, which totaled EUR 4,669,883.08, with a resolution proposing no dividend distribution for this fiscal period.
6. Discharge of the Board members and CEO from liability for the financial year.
7. Decisions regarding the remuneration for the Board members for the upcoming term.
8. Election of Board members, with nominations from the Shareholders' Nomination Board.
9. Setting the number of Board members, with the proposal for six members.
10. Votes on the auditor's remuneration and the appointment of PricewaterhouseCoopers Oy as the company’s auditor until the next AGM.
11. A proposal for new option rights issuance for Board members, the CEO, and other employees as part of incentive programs.
12. Amendments to the Articles of Association regarding the format of holding the General Meetings.

The detailed minutes and documents will become available on Bioretec's website as soon as possible, ensuring transparency for all shareholders.

Importance of Participation

Shareholders play a crucial role in the governance of Bioretec, and their involvement in these meetings can significantly influence the company’s strategic direction and financial health. Furthermore, discussions held during the AGM can directly affect corporate policies and shareholder value.

The Board of Directors asserts that it has thoroughly evaluated the proposed candidates for the Board positions and ensured compliance with independence guidelines for corporate governance. Shareholders should consider the diversity and experience of the nominees as they cast their votes.

Future Prospects

Bioretec continues to pioneer in orthopedic technology and aims for robust company growth as demonstrated in its recent endeavors. The upcoming AGM provides an opportunity for shareholders to align with the company's vision and contribute to its future direction. The company is committed to enhancing its offerings in the medical sector while maintaining accountability and transparency for all stakeholders.

For more detailed information about the AGM, including registration instructions and the latest updates, please visit Bioretec's official website.